European Parliament
President.
Question No 19 by John Bowis 
Subject: Surveillance of cancer, tuberculosis and HIV/AIDS
The Commission will be aware of the importance of surveillance and networking in the areas of cancer, tuberculosis and HIV/AIDS, EU funding for which is due to come to an end with the changes in the Health Action Programme. There will, therefore, be a gap where tuberculosis and HIV/AIDS are concerned until the European Centre for Disease Prevention and Control is established in 2005, and an unquantifiable gap where cancer is concerned. What steps has the Commission been able to take to ensure there are no gaps in the surveillance of these important disease areas?

